Articles

A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma.

Onco-Hematology Division, European Institute of Oncology IRCCS, Milan, Italy;
Division of Diagnostic Haematopathology, European Institute of Oncology IRCCS, Milan, Italy;
Division of Diagnostic Haematopathology, European Institute of Oncology IRCCS, Milan, Italy;
Division of Diagnostic Haematopathology, European Institute of Oncology IRCCS, Milan, Italy;
Division of Diagnostic Haematopathology, European Institute of Oncology IRCCS, Milan, Italy;
Onco-Hematology Division, European Institute of Oncology IRCCS, Milan, Italy;
Hematopathology Unit, Dept of Experimental Diagnostic and Specialty Medicine (DIMES), Bologna, Italy;
NanoString Technologies Inc, Seattle, WA, USA;
Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Milan, Italy;
NanoString Technologies Inc, Seattle, WA, USA;
Hematopathology Unit, Department of Experimental Diagnostic and Specialty Medicine (DIMES), Bologna;
Hematopathology Unit, Dept of Experimental Diagnostic and Specialty Medicine (DIMES), Bologna, Italy;
Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;
Division of Diagnostic Haematopathology, European Institute of Oncology IRCCS, Milan, Italy;
Division of Diagnostic Haematopathology, European Institute of Oncology IRCCS, Milan, Italy;
Division of Diagnostic Haematopathology, European Institute of Oncology IRCCS, Milan, Italy;
Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy;
Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy;
Multidisciplinary Oncology Outpatient Clinic, FPO-IRCCS, Candiolo (Torino), Italy.;
Onco-Hematology Division, European Institute of Oncology IRCCS, Milan, Italy;
Hematology and Bone marrow Transplant Unit, ASST-Papa Giovanni XXIII, Bergamo, Italy;
Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milan, Italy;
Hematology, Dept of Experimental Diagnostic & Specialty Medicine (DIMES), Bologna University, Italy
Onco-Hematology Division, European Institute of Oncology IRCCS, Milan, Italy;
Division of Diagnostic Haematopathology, European Institute of Oncology IRCCS, Milan, Italy;
Haematologica Early view Aug 13, 2020 https://doi.org/10.3324/haematol.2019.236455